Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban and dual antiplatelet for acute ischemic stroke
NCT03552354Phase 4Completed
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Oct 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of argatroban in ischemic stroke, sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Proportion of 1 or more increase in NIHSS at 7 days. Started Oct 2017; status: completed.
02
Drugs
argatroban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03552354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03552354.